Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that its
presentation at the Credit Suisse 2013 Healthcare Conference, originally
scheduled for November 13, 2013, has been rescheduled to November 12,
2013, at 8:00 a.m. MT (10:00 a.m. ET).
A live audio webcast of Infinity’s presentations at the Credit Suisse
conference will be accessible from the “Investors/Media” section of the
company’s website, www.infi.com,
and a replay will be available for 30 days following each event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative biopharmaceutical company dedicated to
discovering, developing and delivering best-in-class medicines to people
with difficult-to-treat diseases. Infinity combines proven scientific
expertise with a passion for developing novel small molecule drugs that
target emerging disease pathways. For more information on Infinity,
please refer to the company’s website at www.infi.com.
Copyright Business Wire 2013